1. Aqeel S, Naheda A, Raza A, Khan W. Biomarkers of disease severity in vivax malaria. Parasitol Res. 2021;120:1437-46. doi:10.1007/s00436-021-07065-3. PMID:33532947.

2. Anvikar A, Van Eijk A, Shah A, Upadhyay K, Sullivan S, Patel A, et al. Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India. Virulence. 2020;11:730-8. doi:10.1080/21505594.2020.1773107 PMid:32490754 PMCid:PMC7549892

3. Rahimi BA, Thakkinstian A, White N, Sirivichayakul C, Dondorp A, Chokejindachai W. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J. 2014;13:481. doi:10.1186/1475-2875-13-481 PMid:25486908 PMCid:PMC4364574

4. Gehlawat V, Arya V, Kaushik J, Gathwala G. Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India. Pathog Glob Health. 2013; 107:210-4. doi:10.1179/2047773213Y.0000000096 PMid:23816514 PMCid:PMC4001474

5. Khan M, Singh D, Bajaj K, Kumar S, Jamal A, Kashyap V, et al. Renal complications of benign tertian malaria: a case-control study from South Delhi, India. J Clin Diagn Res. 2023. doi:10.7860/JCDR/2023/63628.18195

6. Cruz L, Barral-Netto M, Andrade B. Distinct inflammatory profile underlies pathological increases in creatinine levels associated with Plasmodium vivax malaria clinical severity. PLoS Negl Trop Dis. 2018;12:e0006306. doi:10.1371/journal.pntd.0006306 PMid:29596409 PMCid:PMC5875744

7. Naing C, Whittaker M. Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis. Infect Dis Poverty. 2018;7:19. doi:10.1186/s40249-018-0392-9 PMid:29427995 PMCid:PMC5808388

8. Nejati J, Mohebali M, Saghafipour A, et al. Malaria epidemiology in Iran: a systematic review and meta-analysis. Malar J. 2020;19:355. doi:10.1186/s12936-020-03436-8.

9. Anstey N, Handojo T, Pain M, Kenangalem E, Tjitra E, Price R, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis. 2007;195:589-96. doi:10.1086/510756 PMid:17230420 PMCid:PMC2532499

10. Rodríguez-Morales A, Sánchez E, Vargas M, Piccolo C, Colina R, Arria M. Anemia and thrombocytopenia in children with Plasmodium vivax malaria. J Trop Pediatr. 2006;52:49-51. doi:10.1093/tropej/fmi069 PMid:15980019

11. Naing C, Whittaker M, Wai VN, Mak J. Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2014;8:e3071. doi:10.1371/journal.pntd.0003071. PMID:25121491; PMCID:PMC4133404.

12. Sivakorn C, Wilairatana P, Krudsood S, Schultz M, Techarang T, Kheawsawaung K, et al. Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection. Malar J. 2021. doi:10.21203/rs.3.rs-100624/v1

13. Khasawneh SA, Hammamy R, Elhassan A, Mudarres M. Plasmodium vivax malaria complicated with acute respiratory distress syndrome: a case report. Cureus. 2024;16:e66189. doi:10.7759/cureus.66189